Guidance

Importing medicines from the EEA after Brexit

If you import human medicines from the EU, Norway, Iceland or Liechtenstein, you’ll need to review your wholesale dealer’s licence if there’s a no-deal Brexit.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 11 March 2019
• Last updated: 9 October 2019
  Show all updates

  1. 9 October 2019

     Change of text within Stay up to date box.

  2. 4 October 2019

     Updated page titles and the summary to clarify that this guidance is about importing medicines from EEA countries if there's a no-deal Brexit. The rest of the content has not changed.

  3. 11 March 2019

     First published.

This publication was withdrawn on 24 February 2020

For current information see Good manufacturing practice and good distribution practice

Documents

Importing medicines on an approved country for import list in a no-deal Brexit

HTML

Acting as a Responsible Person (import) after Brexit

HTML

Details

In a no-deal Brexit existing wholesale dealers that source human medicines from an EEA State for use in the UK will need to review their existing wholesale dealer’s licence.

This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.